|Hastings, did you learn any more after contacting them? I am quite new into Pennant, so don't have enough feel for how crucial Snook has been to the business, and whether it can still develop without him. It had felt like they were on a roll, lots of contract win and next year already well underpined|
|I am no longer a holder but was a long term holder, I got out at 85 in July'14 having doubled my money. I attended the AGM twice and got the impression that Mr. Snook was the only director with his finger on the button and as such was given pretty much a free rein by Mr.Powell, I felt also that Mr. Snook was the man behind the innovation and technical side of things. However since I sold out new blood has come into the company (Mr. Moore and Mr.Walker)consequently I feel that there must have been conflict between the old and the new, unless Mr. Snook has been headhunted, in any case Mr. Snook will be a hard act to follow.|
Thank you for your commiseration. We all have our ups and downs in this business !
I have now found my hard copy of PEN's Financial Statements at 31 Dec. 2015 and looked at the terms of the 1,400,000 B shares issued to Mr. Snook and of the 700,000 C shares issued to Mr. Walker. The B & C shares have identical rights..
For these shares to have value the company must be sold at a price in excess of 100p per share or a capital distribution of this amount is made on a liquidation.
In this event the B & C shares will be worth the excess over 91p of this price.
They were allotted to Messrs S & W at 0.005p and these modest amounts (£7,000 & £3,500) will be repaid to either or both of them on their ceasing to be directors and full-time employees.
At 31.12.2015 Mr Snook also held nearly 1,500,000 ord shares but a recent post reminds us that he sold some when new capital was subscribed last year. His total remuneration in 2015 was £288,070 compared with £405,141 in 2014.|
|Hi Varies, sorry you are feeling a touch sore, hopefully PEN will not now come out with anything untoward.I would have thought had it been anything financial then the FD would be walking.That said the tone suggests to me perhaps some sort of falling out, although equally it may be nothing of the sort.|
|This is always a thin market and I doubt if one could sell many shares at over 80p if one wanted to.
The web-site shows that Mr. Snook is aged 56 and has been CEO since 2005. Mr Walker is aged only 36; his qualifications are purely financial.
The non-execs are Mr Moore (chairman) aged 50 and Mr Powell aged 69. Mr P is still the largest shareholder with 19% and Hargreave Hale the 2nd largest with 13%.
I find this announcement worrying.
If Mr. Powell is still in good health and taking a lively interest in the company, then I hope he will take over.
I believe that both Mr Snook and Mr Walker have share options and I wonder if Mr Snook's now lapse.
We certainly need more information and I hope nothing horrid will be unveiled;
I had a nasty shock this morning from NCC and am feeling rather tender !|
|Might have been missed PJ1?
I have PEN on my watchlist after the positive trading update last month, but have only just noticed yesterdays RNS, but of course that could be more to do with me not being on the ball.|
|The 'subdued' response of -3% would indicate the Market expected it?
Unless the RNS was missed by most?|
|Agreed, it was short and sharp, trying to find out a bit more, but suspect I might not be successful.|
|"stepped down with immediate effect"
Anybody know anything more? Snook did sell 2/3 of his shareholding last year so perhaps indicates his outgoing mindset. There are only 2 executive directors on the board so not much scope for a fallout. I think personal or health reasons, we can understand that, but a little explanation would have been helpful.|
|last chances under 100p|
|Thanks Hastings, an excellent write up, really appreciated.|
|Simso, write up below from my Cambridge News slot may be of interest.
I spoke with both the CEO and FD on Interim results day and in penning the piece quoted the broker numbers, which remain intact. The only difference is on the target price, which has been lifted to £1.10p.
As a holder, I am hoping for some additional contracts to be announced in the coming months which would no doubt make a material difference to 2017/2018.
I'm catching up with management again at the prelims.
Pennant International's interim results earlier this week may not have set the world alight in terms of numbers, share price appreciation, or for that matter coverage, but they have at least since seen another stirring of interest.
Whilst the shares had already enjoyed a great run, there was subsequently a bout of selling from the high sixties in the run up to the results, before some steady buying in the latter part of the week took the shares back up to a 68p Friday close.
Whilst for some watchers of Pennant there has been a view of too much to do for the delivery of the £2.2m full year pre-tax profit with a hefty second half weighting, it would seem that any such fears on that front may be well and truly overdone.
Speaking once more with CEO Chris Snook and FD Phil Walker on the day of the results I raised the very question in relation to the full year performance and an expected delivery of being at risk.
To this end, there was an emphatic and positive view that the company would very much deliver and that the board certainly doesn't envisage any hiccups in the run up to the finals.
Further to that, CEO Snook says they are already punching on for 2020 as the pipeline and prospects for the company continue building on the more recent and positive momentum.
Alongside this, Snook says that the first of its three additional and recently acquired facilities commences production next week, the second soon after, with the third coming on stream slightly further down the line all of which should meet both current and expected demand.
They board has also been busy lining up client visits, where it transpires that one major overseas visitor dropped in last week, which follows on from presentations to both existing and potential investors which the CEO said totalled a high teen number as opposed to just a few that featured not so long back.
Such appears to be the ambition to move the business further forwards and secure long term growth with diminishing lumpiness that both were happy to talk about the current solid order book, the strong pipeline of real opportunities and a serious intention to acquire another business to complement its organic growth.
That doesn't mean to imply there is another placing on the cards any time soon, as Pennant is now in a healthy enough position as demonstrated by the interim results numbers.
There was cash on the balance sheet of £2.6m which includes advances on
contracts, although importantly pre-dates the £3.6m fund-raise of August this year and the £1m purchase of property.
The YoY contrast is with £0.6m net debt figure at end of H1-15 against the £1m-plus cash generated in H1-16.
As the revenue builds so should profit, dropping straight to the bottom line says Snook, which appears to be increasing on the back of much improved prospects.
Phil Walker also confirmed that as a result of the progress being made, they are absolutely committed to resuming dividend payments as soon as is right and prudent.
“It is something we are very mindful of and certainly recognise the importance of dividends to our shareholders”.
Timing on this front will of course come down to the right boxes being ticked, but it does not seem beyond the realms of possibility that this could happen on the delivering of the preliminary results early next year.
On the very healthy, sizeable and what is a record order book, Snook says the current and significant middle eastern contracts are actually running in parallel, with both contributing to an overall expected full year sales figure of £17.3m which next year will edge up to the already visible £18m.
Importantly, these numbers are already in the bag as other contracts with Lockheed Martin and General Dynamics unwind with 100% visibility for the remainder of this year and all of next year, so any one of a large number of existing pipeline prospects being delivered in the coming months would almost certainly make a material difference to next years numbers and provide further support into 2018 and beyond.
To give a flavour of the potential upside on the Training Systems arm which currently accounts for 75% of revenue, there are at present several live near term prospects in play, where if just one or two are successful, it would not only provide another timely boost to the story but present additional longer term credibility.
Pennant would now seem to be be well placed in a market that has received a significant boost in terms of investment, which plays well into its hands as one that provides the key specialist skills that are increasingly needed within new areas, not merely defence, but rail and aerospace which also takes in new markets and territories.
The company has recently successfully concluded a contract in India which is worth noting, but whilst that growth country does provide for further opportunity's, the board doesn't see this as being a major revenue earner, as it cites other existing regions offering more extensive and lucrative growth potential.
Having earlier this year appointed a new Chairman the company has now announced that it has brought on board a non exec Director with seemingly strong credentials.
Tim Rice has some thirty years of extensive experience across both the defence and aerospace sectors through roles at Safran, Spirent and Dowty and his presence should further assist the company going forward in terms of raising its profile and prospects.
For now, WH Ireland is forecasting pre-tax profits this year of £2.2m and EPS of 7.4P giving a PER of 9, which remains at a considerable discount to the sector average of 21.
Looking to next year, although the pre-tax profit increases to £2.4m, EPS actually reduces to 7.1p, implying a forward PER of 9.5, before heading back to to EPS OF 7.4P in 2018 as profit is expected to hit £2.6m.
The reason for this is down to the factoring in of new shares issued via the placing earlier this year.
However, there would seem to be a distinct possibility that Pennant will indeed secure at least one, two or possibly more of those current targeted deals, which depending on the size and time scale would no doubt provide for an upgrade from the broker.
It is also worth noting that the board reiterates that it sees no potential downside from brexit and if anything, given its extensive export profile Pennant should be well placed to extend its already broadening reach and profit from a weaker pound.
WH Ireland states that it is comfortable in raising its target price to 80p which should really be achievable in the near term and possibly exceeded if news of further wins are announced over the next six months or so along with a signalling of reinstating the dividend.
Pennant has been a good story over recent years aside the delayed contract issues of just over a year ago and certainly seems to have got its mojo back.
Although I guess lumpiness will never completely disappear, the picture for the next two or three years looks intact providing scope for a longer term visibility and earnings appreciation.|
|Has anyone got access to the WH Ireland Forecast, and what Sales and EPS in predicts for the year ahead (2017)?
I can see summaries from different websites of the "Current Broker View" which don't all agree with each other...but my most reliable site seemed to forecast £18m of Sales and £2.4m PBT (EPS 7.9p).
Clearly a lowly P/E even now at just over 10* Earnings. If the £18m Sales and £2.4m PBT are indeed the correct brokers forecasts, then arguably the £18m sales for 2017 were already in the bag by September 2016 according to this quote from SA Moore at the Interims:
"future contracted Order Book, valued in aggregate at more than £46 million ... with delivery currently scheduled as to £18 million in FY2017...". Taken at face value and assuming this £18m is contractually secure, then surely there is significant opportunity to increase on that number with other contracts and work, and beat this Brokers forecast?
I would love to know the Sales and PBT number in the latest forecast, if anyone has access to it or at least a summary of it?|
|Very firm on keeping this as a lt hold.|
|Excellent update this morning reinforcing earlier view.|
|Also enjoyed a good run on this, but happy to sit tight.I'm not so sure that the Middle Eastern business is all with New Customers.Rather, a Country where PEN has been active before and one that is new.Given the length of such contracts one would hope (assume) the company has payment structured adequately.Both the CEO and FD were extremely confident in delivering the forecast numbers and if that is the case, then the shares really should have further to go from the current level.Interesting too that the broker target price was upped to £1.00 earlier this month.|
|Yes, its recovered well. High risk / reward scenario - main risk is whether its new customers in the Middle East pay on time in my view.|
|This has recovered to become one of my better performers.
Possibly we could see a new all time high in 2017.|
|May be of some interest to others here.
|Hi Varies, from the placing document.
An oversubscribed Firm Placing of 2,504,200 Ordinary Shares of 5 pence each, utilising the Company’s existing share authorities, at a price of 55 pence per share to raise £1,377,310 (before expenses); and an oversubscribed Conditional Placing of 3,967,072 Ordinary Shares of 5 pence each at a price of 55 pence per share to raise £2,181,890 (before expenses)
The Firm Placing comprises the placing of 1,527,739 Ordinary Shares held in treasury and the allotment and issue of 976,461 new Ordinary Shares, in each case at a price of 55 pence per share. A total of £1,377,310 (before expenses) has been has been raised by way of the Firm Placing utilising the existing share authorities granted at the 2016 AGM.|
|The no. of share figures you have quoted above were for the firm placing, in parallel there was a conditional placing (requiring shareholder approval) raising approx £2.2m.|
|It is disappointing that the payment of dividends is suspended until further notice although I can see that the money is needed for expansion of our capacity.
We are told that since 30.06.2016 PEN has raised £3,560,000 before expenses through the issue of shares, 1,527,000 + 977,000 @ 55p.
2,504,000 x 55p = £1,377,200. So there is a mistake here.
It does look as if we should make a bumper profit in 2017. Let us hope that our customers make good progress payments and that dividends can be resumed in 12 months time.|
|Agreed, broker target price lifted with comfort to 80p.|
|Looking good - losses eliminated, positive cash flow and a record order book.
RNS Number : 8785K
Pennant International Group PLC
27 September 2016
Interim Results for the six months ended 30 June 2016
Return to profit; Trading in line with market expectations;
Four new contracts secured; Strategic new customers including Lockheed Martin Corporation; Record Group Order Book of £46m at Period-End;
Pennant International Group plc ("Pennant" or "the Group"), the AIM quoted supplier of integrated logistic support solutions, products and services, principally to the defence, rail, aerospace and naval sectors and to Government Departments, announces Interim Results for the six months ended 30 June 2016.
Commenting on the results and the Group's prospects for the year as a whole, new Chairman Simon Moore said: "The Group recorded a modest pre-tax profit for the six months ended 30 June 2016, an outcome that is significantly better than the equivalent period last year. Furthermore, as highlighted in the Trading Update announced in June, the directors expect a substantial improvement in trading in the second half and, based on the levels of the confirmed record Order Book, are confident of a successful outcome for the year as whole."
· Group revenues for the period of £6.6m (2015: £5.7m);
· Profit before tax of £10,582 (2014: loss before tax £0.75m);
· Profit for the period attributable to shareholders of £10,582 (2015: loss £0.75m)
· Cash generated from operations of £1.2m (2015: cash used in operations of £(1.0) m);
· Nil borrowings; Net cash at period end of £2.6m (2015: £(0.6)m);
· Basic earnings per share of 0.04p (2014: loss of (2.86p) per share);
· No Interim dividend declared (2015: 1.0p);
· Record Order Book: £46mn at Period-End including £36m for delivery in 2017, 2018 & 2019
· Effective nil tax rate; unrelieved tax losses of £4.7m;
· Minimal impact of Brexit on Group, other than short term currency fluctuations;
· Post period-end, an oversubscribed share issue at 55p per share to raise £3.56m before expenses to provide additional working capital for new and existing contracts;
· Secured second phase contract with undisclosed Middle Eastern customer worth in excess of £7m;
· Secured the first phase of a supply contract with a new strategic Middle Eastern customer worth £6m;
· Awarded new landmark contract with Lockheed Martin Corporation MST (LMC) with potential value of £2.2m over 18 months;
· Secured second contract with LMC to provide Rotary Wing Rear Crew Winch Trainer (RCWT) in support of Rear Crew Training for the United Kingdom Military Flight Training System (UKMFTS);
· Successful completion of contract with an Indian customer for the provision of software based training capability;
· Re-profiling of strategic single source contract due to run rate progressing ahead of expected levels. Early discussions commenced to renew the contract and increase its value;
· Sale of new licenses for the use of the Group's Integrated Logistics Support Software product, OmegaPS, to Oshkosh.
Mr. Moore concluded: "The Board remains confident that trading will be in line with current market expectations for the year ending 31 December 2016. Notwithstanding the current global economic outlook, to date, we have seen very little noticeable impact on the Group's trading from the Brexit vote. Prospects for next year and beyond remain very positive with the future contracted Order Book, valued in aggregate at more than £46m including £36m with delivery currently scheduled as to £18m in FY2017, £10m in FY2018 and £8m in FY2019, providing good long-term visibility of revenues."|
|Results next Tuesday and catching up with management, so will be penning something on the back of that.|